NeuroOne Medical Technologies (NeuroOne Medical Technologies) FCF Yield % : -41.46 (As of May. 26, 2024)

View and export this data going back to 2012. Start your Free Trial

What is NeuroOne Medical Technologies FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, NeuroOne Medical Technologies's Trailing 12-Month Free Cash Flow is $-12.09 Mil, and Market Cap is $29.17 Mil. Therefore, NeuroOne Medical Technologies's FCF Yield % for today is -41.46%.

The historical rank and industry rank for NeuroOne Medical Technologies's FCF Yield % or its related term are showing as below:

NMTC' s FCF Yield % Range Over the Past 10 Years
Min: -120.89 Med: -35.3 Max: -5.01
Current: -41.46

During the past 13 years, the highest FCF Yield % of NeuroOne Medical Technologies was -5.01%. The lowest was -120.89%. And the median was -35.30%.

NMTC's FCF Yield % is ranked worse than
85.52% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: -2.815 vs NMTC: -41.46

NeuroOne Medical Technologies's FCF Margin % for the quarter that ended in Mar. 2024 was -160.20%.

NeuroOne Medical Technologies FCF Yield % Historical Data

The historical data trend for NeuroOne Medical Technologies's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuroOne Medical Technologies FCF Yield % Chart

NeuroOne Medical Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

FCF Yield %

Get a 7-Day Free Trial

-65.62

-37.33

-18.28

-28.44

-62.29

NeuroOne Medical Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-54.85	-57.46	-55.59	-39.21	-27.94

Competitive Comparison of NeuroOne Medical Technologies's FCF Yield %

For the Medical Devices subindustry, NeuroOne Medical Technologies's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeuroOne Medical Technologies's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NeuroOne Medical Technologies's FCF Yield % distribution charts can be found below:

* The bar in red indicates where NeuroOne Medical Technologies's FCF Yield % falls into.

NeuroOne Medical Technologies FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

NeuroOne Medical Technologies's FCF Yield % for the fiscal year that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-13.271	/	21.30629256
	=	-62.29%

NeuroOne Medical Technologies's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2.206	*	4	/	31.58616
	=	-27.94%

NeuroOne Medical Technologies FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

NeuroOne Medical Technologies FCF Yield % Related Terms

Thank you for viewing the detailed overview of NeuroOne Medical Technologies's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

NeuroOne Medical Technologies (NeuroOne Medical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NeuroOne Medical Technologies Corp (NAS:NMTC) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7599 Anagram Dr., Eden Prairie, MN, USA, 55344

Website

https://www.n1mtc.com

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

Executives

Mark Christianson	10 percent owner, officer: VP, Business Dev and Marketing	10006 LIATRIS LANE, EDEN PRAIRIE MN 55347
Ronald W. Mcclurg	officer: Chief Financial Officer	C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DR, EDEN PRAIRIE MN 55344
David A Rosa	director, officer: CEO and President	10901 RED CIRCLE DRIVE, SUITE 150, MINNETONKA MN 55343
Hijaz Haris	officer: VP of Marketing	C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DR, EDEN PRAIRIE MN 55344
Morgan C. Frank	10 percent owner	2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02110
Manchester Explorer, L.p.	10 percent owner	MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
James E Besser	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02114
Manchester Management Pr, Llc	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02114
Edward Andrle	director	C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DRIVE, EDEN PRAIRIE MN 55344
Wade Fredrickson	10 percent owner	10006 LIATRIS LANE, EDEN PRAIRIE MN 55347
Steve Mertens	officer: Chief Technology Officer	10901 RED CIRCLE DR., SUITE 150, MINNETONKA MN 55343
Scott Heuler	officer: Vice President of Sales	10901 RED CIRCLE DR., SUITE 150, MINNETONKA MN 55343
Paul Buckman	director	12988 VALLEY VIEW RD, EDEN PRAIRIE MN 55402
Suraj Kalia	director	10006 LIATRIS LANE, EDEN PRAIRIE MN 55347